SCHEMBL14045656

SCHEMBL14045656

CCOC(=O)CN(CC)CCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.52
SCN1A P35498 2/20 0.48
SCN2A Q99250 2/20 0.48
SCN3A Q9NY46 2/20 0.48
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD1 P21728 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
OPRM1 P35372 1/20 0.47
DRD3 P35462 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47
LTA4H P09960 1/20 0.47
ACHE P22303 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13541712 0.84 L3MBTL1 (0.51) LTA4HACHECA12CA1CA2
SCHEMBL1491714 0.84 ALOX5 (0.46) ALOX5LTA4HSMN1; SMN2ABCB1PPID
SCHEMBL14660352 0.83 ALOX5 (0.60) ALOX5OPRM1DRD3LTA4HL3MBTL1
SCHEMBL3184733 0.82 ALDH1A1 (0.54) ALOX5LTA4HL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL10188366 0.82 ALOX5 (0.44) ALOX5LTA4HACHECA1CA2
SCHEMBL254781 0.81 ALDH1A1 (0.53) ALOX5LTA4HL3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL20506778 0.80 ALDH1A1 (0.49) ALOX5LTA4HACHEL3MBTL1SMN1; SMN2
SCHEMBL13994260 0.80 OPRM1 (0.51) SCN1ASCN2ASCN3ACHRM2HTR1A
SCHEMBL8418693 0.80 AOC3 (0.51) SCN1ASCN2ASCN3ACHRM2HTR1A
SCHEMBL14024656 0.79 ALOX5 (0.50) ALOX5LTA4HL3MBTL1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255126-A1 Inhibitors of post-proline cleaving proteases FERRING B.V. 2008-10-16 US disclosed
US-7335677-B2 Inhibitors of dipeptidyl peptidase IV FERRING B.V. (NL) 2008-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255126-A1 Inhibitors of post-proline cleaving proteases PREP, PEPD, DPP4 ALOX5 4039/4885SCN1A 2134/4885SCN2A 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.